Rosacea Fulminans following Initiation of Deucravacitinib

Rosacea fulminans developed in a middle-aged caucasian man 10 days after initiating Deucravacitinib for chronic plaque psoriasis. The painful papulopustular eruption resolved without scarring after discontinuation of deucravacitinib, and treatment with a short-course of oral prednisolone. This case is notable as it is the first reported instance of rosacea fulminans linked to the use of a JAK inhibitor.